← All companies

KRRO

Korro Bio, Inc.

KRRO Nasdaq Pharmaceutical Preparations EDGAR ↗

$10.74

+0.29 +2.78%

Key statistics

from XBRL data in SEC filings

Market cap

$155M

Revenue (TTM)

$3.84M

Net income (TTM)

-$113M

EPS (TTM)

$-11.68

P/E ratio

—

Dividend yield

—

Free cash flow

-$79.1M

Cash

$61.7M

Total assets

$184M

Gross margin

—

52-week range

$5.20 – $55.89

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 11, 2026 8-K Other events May 19, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Results of operations (earnings release) Mar 12, 2026 8-K Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity; Regulation FD disclosure Mar 9, 2026 8-K Other events Jan 27, 2026 8-K Other events Jan 15, 2026 8-K Director or officer change Dec 18, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Entered a material agreement; Results of operations (earnings release); Exit or disposal costs; Director or officer change Nov 12, 2025 8-K Director or officer change Oct 8, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K/A Shareholder vote results Jun 18, 2025 8-K Shareholder vote results Jun 11, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Results of operations (earnings release); Exit or disposal costs May 7, 2025 8-K Director or officer change Mar 27, 2025 10-K Fiscal year ended 2024-12-31 Mar 18, 2025 8-K Results of operations (earnings release) Mar 18, 2025 8-K Director or officer change Feb 11, 2025 8-K Other events Jan 13, 2025 8-K Other events Nov 21, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Other events Nov 4, 2024 8-K Entered a material agreement Sep 16, 2024 8-K Director or officer change Aug 28, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release) Aug 13, 2024 8-K Director or officer change Jun 21, 2024 8-K Amended charter or bylaws; Shareholder vote results Jun 12, 2024 8-K Other events May 14, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Results of operations (earnings release) May 14, 2024 8-K Other events Apr 22, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Apr 18, 2024 8-K Results of operations (earnings release) Mar 26, 2024